PreveCeutical Medical Inc. (PREV.CN)
CAD 0.02
(0.0%)
CAD 0.02
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 3.83 Million CAD | 18.81% |
| 2022 | 3.22 Million CAD | 10.74% |
| 2021 | 2.91 Million CAD | 2.0% |
| 2020 | 2.85 Million CAD | -39.5% |
| 2019 | 4.72 Million CAD | 31.59% |
| 2018 | 3.58 Million CAD | 36.75% |
| 2017 | 2.62 Million CAD | 1368.95% |
| 2016 | 178.59 Thousand CAD | 1733.96% |
| 2015 | -10.93 Thousand CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 4.19 Million CAD | 4.11% |
| 2024 Q1 | 4.03 Million CAD | 5.17% |
| 2023 Q4 | 3.83 Million CAD | 1.5% |
| 2023 Q3 | 3.77 Million CAD | 5.26% |
| 2023 Q2 | 3.58 Million CAD | 5.53% |
| 2023 Q1 | 3.39 Million CAD | 5.37% |
| 2023 FY | 3.83 Million CAD | 18.81% |
| 2022 Q4 | 3.22 Million CAD | -3.8% |
| 2022 Q2 | 2.97 Million CAD | 4.2% |
| 2022 Q1 | 2.85 Million CAD | -2.12% |
| 2022 FY | 3.22 Million CAD | 10.74% |
| 2022 Q3 | 3.35 Million CAD | 12.86% |
| 2021 Q1 | 2.5 Million CAD | -12.4% |
| 2021 Q2 | 2.78 Million CAD | 11.34% |
| 2021 Q3 | 2.64 Million CAD | -5.22% |
| 2021 Q4 | 2.91 Million CAD | 10.34% |
| 2021 FY | 2.91 Million CAD | 2.0% |
| 2020 Q1 | 4.75 Million CAD | 0.65% |
| 2020 Q2 | 3.22 Million CAD | -32.12% |
| 2020 Q3 | 2.74 Million CAD | -15.03% |
| 2020 Q4 | 2.85 Million CAD | 4.22% |
| 2020 FY | 2.85 Million CAD | -39.5% |
| 2019 Q3 | 4.93 Million CAD | 3.6% |
| 2019 FY | 4.72 Million CAD | 31.59% |
| 2019 Q2 | 4.75 Million CAD | 7.66% |
| 2019 Q4 | 4.72 Million CAD | -4.25% |
| 2019 Q1 | 4.42 Million CAD | 23.22% |
| 2018 FY | 3.58 Million CAD | 36.75% |
| 2018 Q1 | 3.44 Million CAD | 31.22% |
| 2018 Q2 | 930.11 Thousand CAD | -72.98% |
| 2018 Q3 | 2.5 Million CAD | 168.9% |
| 2018 Q4 | 3.58 Million CAD | 43.44% |
| 2017 Q1 | -177.13 Thousand CAD | -1482.92% |
| 2017 Q2 | 126.16 Thousand CAD | 171.22% |
| 2017 Q3 | 1.92 Million CAD | 1427.4% |
| 2017 Q4 | 2.62 Million CAD | 36.14% |
| 2017 FY | 2.62 Million CAD | 1368.95% |
| 2016 FY | 178.59 Thousand CAD | 1733.96% |
| 2016 Q1 | - CAD | 0.0% |
| 2016 Q4 | 12.8 Thousand CAD | 182.24% |
| 2016 Q3 | -15.57 Thousand CAD | -130.6% |
| 2016 Q2 | 50.9 Thousand CAD | 0.0% |
| 2015 FY | -10.93 Thousand CAD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Algernon Pharmaceuticals Inc. | -125.08 Thousand CAD | 3164.108% |
| Asep Medical Holdings Inc | -44.72 Thousand CAD | 8670.336% |
| BetterLife Pharma Inc. | 207.85 Thousand CAD | -1743.993% |
| BioVaxys Technology Corp. | -977.00 CAD | 392396.827% |
| ChitogenX Inc. | 3.84 Million CAD | 0.189% |
| Rapid Dose Therapeutics Corp. | 2.29 Million CAD | -67.178% |
| Defence Therapeutics Inc. | 1.68 Million CAD | -126.803% |
| Entheon Biomedical Corp. | -344.63 Thousand CAD | 1212.122% |
| Gemina Laboratories Ltd. | 284.33 Thousand CAD | -1247.962% |
| Glow Lifetech Corp. | 116.15 Thousand CAD | -3199.819% |
| Lexston Life Sciences Corp. | -390.4 Thousand CAD | 1081.734% |
| Pharmala Biotech Holdings Inc. | 58.49 Thousand CAD | -6452.252% |
| Doseology Sciences Inc. | -1.06 Million CAD | 461.504% |
| MYND Life Sciences Inc. | 2.99 Million CAD | -27.769% |
| Nova Mentis Life Science Corp. | -8088.00 CAD | 47487.982% |
| PharmaTher Holdings Ltd. | -2.13 Million CAD | 279.668% |
| Telescope Innovations Corp. | -719.49 Thousand CAD | 632.7% |